Skip to Content

Zhejiang Guobang Pharm , China, 2022

GMP Audit Report

Company
Zhejiang Guobang Pharm

Product(s)
Marbofloxacin

Country
China

Audit Year
2022

0.00 € 0.00 €
0.00 €